Sensorion Launches a Capital Increase by Means of an Accelerated Bookbuild Offering
(WorldNews France)

Sensorion Launches a Capital Increase by Means of an Accelerated Bookbuild Offering 17 Sep 2020 19:33 CEST Company Name SENSORION ISN FR0012596468 Market Euronext Growth Symbol ALSEN Regulatory News: Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This press release is not intended as an offer and is for informational purpose only Sensorion (FR0012596468 - ALSEN - the `Company`) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, intends to issue new ordinary shares of a nominal value of...